Phase II Study of Enzalutamide for Patients With Androgen Receptor–Positive Salivary Gland Cancers (Alliance A091404)

By A. Ho, N. Foster, A. Zoroufy, J. Campbell, F. Worden, K. Price, D. Adkins, D. Bowles, Hyunseok Kang, B. Burtness and 7 more. 2022